Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABT

Abbott Laboratories (ABT)

Abbott Laboratories
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABT
DateTimeSourceHeadlineSymbolCompany
05/15/20259:05AMPR Newswire (US)Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with DiabetesNYSE:ABTAbbott Laboratories
05/07/20259:00AMPR Newswire (US)Abbott and Real Madrid Kick Off Search to Empower Young Soccer TalentNYSE:ABTAbbott Laboratories
05/02/20255:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/01/20254:01PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
05/01/20259:00AMPR Newswire (US)MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at RacesNYSE:ABTAbbott Laboratories
04/30/20254:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
04/30/20254:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ABTAbbott Laboratories
04/29/20256:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/29/20256:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/29/20256:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/29/20255:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/29/20255:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/29/20255:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/29/20255:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/29/20259:05AMPR Newswire (US)Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring InformationNYSE:ABTAbbott Laboratories
04/28/20254:10PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
04/27/20252:15PMPR Newswire (US)Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing TechnologyNYSE:ABTAbbott Laboratories
04/26/20257:15PMPR Newswire (US)New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFibNYSE:ABTAbbott Laboratories
04/26/20257:15PMPR Newswire (US)New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFibNYSE:ABTAbbott Laboratories
04/16/20257:36AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
04/16/20257:30AMPR Newswire (US)Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year GuidanceNYSE:ABTAbbott Laboratories
04/02/20255:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/31/20259:00AMPR Newswire (US)New Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
03/27/20259:00AMPR Newswire (US)Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsNYSE:ABTAbbott Laboratories
03/27/20259:00AMPR Newswire (US)Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsNYSE:ABTAbbott Laboratories
03/26/20259:00AMPR Newswire (US)Abbott Hosts Conference Call for First-Quarter EarningsNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:NYSE:ABT